Xianbin Meng

The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery

Yun Xia, Yonghua Xie, Zhengsen Yu et al. · Cell · 2018 · 253 citations · Full text

Pharmacy, Immunology, Pharmacology +16

Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy

Xuejing Shao, Tianbai Zhong, Yue Wu et al. · Nature Chemical Biology · 2021 · 159 citations

Medicine, Cancer Biology, Molecular Medicine +10

Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironment

Jie Cheng, Jinxin Yan, Ying Liu et al. · Cell Metabolism · 2023 · 158 citations · Full text

Medicine, Immunology, Oncology +17

Cysteine-Aminoethylation-Assisted Chemical Ubiquitination of Recombinant Histones

Guo‐Chao Chu, Man Pan, Jiabin Li et al. · Journal of the American Chemical Society · 2019 · 104 citations

Life Sciences, Chemical Biology, Molecular Biology +15

SLC22A14 is a mitochondrial riboflavin transporter required for sperm oxidative phosphorylation and male fertility

Wenhua Kuang, Jie Zhang, Lan Zhou et al. · Cell Reports · 2021 · 98 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17